Gleevec (Novartis Pharma Produktions GmbH)
Welcome to the PulseAid listing for the Gleevec drug offered from Novartis Pharma Produktions GmbH. This Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharma Produktions GmbH |
| NON-PROPRIETARY NAME: | imatinib mesylate |
| SUBSTANCE NAME: | IMATINIB MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2001-05-15 |
| END MARKETING DATE: | 0000-00-00 |
Gleevec HUMAN PRESCRIPTION DRUG Details:
| Item Description | Gleevec from Novartis Pharma Produktions GmbH |
| LABELER NAME: | Novartis Pharma Produktions GmbH |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2001-05-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 66828-0030_d56c24fb-196d-4775-b67f-13c5e41bd150 |
| PRODUCT NDC: | 66828-0030 |
| APPLICATION NUMBER: | NDA021588 |
Other IMATINIB MESYLATE Pharmaceutical Manufacturers / Labelers:
